MERSANA THERAPEUTICS

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 أغسطس 2023 16:05:52 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics Announces Topline Data from UPLIFT Clinical Trial in Patients with Platinum-Resistant Ovarian Cancer and Strategic Reprioritization

27 يوليو 2023 07:06:23 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 يوليو 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials

15 يونيو 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 يونيو 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics to Present at Upcoming Investor Conferences

24 مايو 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results

09 مايو 2023 07:00:01 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 مايو 2023 16:05:01 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics to Present at Bank of America Securities 2023 Healthcare Conference

03 مايو 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics to Host First Quarter 2023 Conference Call on May 9, 2023

02 مايو 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics Announces Upcoming Presentations at 2023 ASCO Annual Meeting

26 أبريل 2023 16:05:01 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 أبريل 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics Announces Clinical Hold on XMT-2056 Phase 1 Clinical Trial

13 مارس 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics Provides Statement About SVB

10 مارس 2023 19:10:38 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 مارس 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics to Host Fourth Quarter and Year End 2022 Conference Call on February 28, 2023

21 فبراير 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 فبراير 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics to Present at Upcoming Investor Conferences

02 فبراير 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics Initiates Expansion Portion of UPGRADE-A Combination Clinical Trial in Platinum-Sensitive Ovarian Cancer

01 فبراير 2023 08:00:01 بحسب Nasdaq GlobeNewswire

Mersana Therapeutics Announces Initiation of Phase 1 Trial of XMT-2056 in HER2-Expressing Tumors

25 يناير 2023 08:00:01 بحسب Nasdaq GlobeNewswire